VOR Vor Biopharma
Price Chart
Executive Summary
Vor Bio granted stock options and RSUs to 8 new employees as inducement awards under its 2023 Inducement Plan. The awards cover 215,700 stock options and 46,235 RSUs, with exercise prices ranging from $7.95 to $24.11 per share, reflecting market closing prices on grant dates.
Actionable Insight
Monitor insider activity and future hiring trends; no immediate financial impact, but increasing headcount may signal expansion of clinical development efforts.
Key Facts
- Granted stock options for 215,700 shares and RSUs for 46,235 shares to 8 new employees
- Awards made in November 2025 and March 23, 2026 under Nasdaq Listing Rule 5635(c)(4) as material inducements
- Stock options have 10-year term, exercise price equals closing price on grant date ($7.95–$24.11)
- Options and RSUs vest over four years: 25% after 12 months, remainder monthly (options) or quarterly (RSUs)
- No financial performance data, revenue, or clinical updates included
Financial Impact
Minimal near-term financial impact; potential future dilution of ~0.5% based on ~261,935 total shares granted and $500M market cap
Risk Factors
- Future dilution from vesting of options and RSUs
- No performance-based vesting terms disclosed — compensation is time-vested only
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3260855 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
1d ago
|
Press Release
| $13.10 awaiting T+20 | awaiting T+20 | — | $13.28 (+1.37%) |
|
May 7, 2026
4w ago
|
EFFECT
| $16.08 $13.44 | ▼ −16.42% | ▼ −19.55% | $13.28 (−17.41%) |
|
Apr 27, 2026
6w ago
|
S-3
| $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $13.28 (−7.65%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $13.28 (−7.65%) |
|
Mar 27, 2026
10w ago
|
Press Release
| $14.48 $14.12 | ▼ −2.49% | ▼ −15.23% | $13.28 (−8.29%) |
|
Mar 23, 2026
11w ago
|
Press Release
| $12.15 $15.32 | ▲ +26.09% | ▲ +17.19% | $13.28 (+9.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access